| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/29/2004 | WO2004062561A2 Pharmaceutical compositions comprising fentanyl for intranasal delivery |
| 07/29/2004 | WO2004062560A2 Pharmaceutical composition |
| 07/29/2004 | WO2004062559A2 Use of microcapsules comprising an antigen for the manufacture of an ex-vivo medicament to initiate an immune response |
| 07/29/2004 | WO2004062552A2 Pharmaceutical composition containing a nsaid and a benzimidazole derivative |
| 07/29/2004 | WO2004062538A1 Condom coated with lactobacillus compositions |
| 07/29/2004 | WO2004062461A2 Therapeutic microfoam |
| 07/29/2004 | WO2004050123A3 Concentrated liquid valdecoxib composition |
| 07/29/2004 | WO2004050021A3 Methods and compositions for applying pharmacologic agents to the ear |
| 07/29/2004 | WO2004050011A3 High enantiomeric purity dexanabinol for pharmaceutical copositions |
| 07/29/2004 | WO2004047798A3 Formulations of finasteride |
| 07/29/2004 | WO2004047713A3 Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs |
| 07/29/2004 | WO2004043480A3 Intraocular administration of cyclosporin a for the treatment of macular degeneration, retinopathy or retinitis pigmentosa |
| 07/29/2004 | WO2004043430A3 Botulinum toxin formulations for oral administration |
| 07/29/2004 | WO2004041166A3 Dosage forms containing stabilized choline and method for preparing same |
| 07/29/2004 | WO2004037173A3 Method for treating erectile dysfunction and increasing libido in men |
| 07/29/2004 | WO2004034959A3 Multiparticulate modified release composition comprising beraprost |
| 07/29/2004 | WO2004032866A3 Therapeutic formulations |
| 07/29/2004 | WO2004019910A3 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract |
| 07/29/2004 | WO2004017971A8 Use of a papaverine-like vasodilator and pharmaceutical composition |
| 07/29/2004 | WO2004010972A3 Pellicle-resistant gelatin capsule |
| 07/29/2004 | WO2003105811A3 Controlled release compositions and methods for using same |
| 07/29/2004 | WO2003103582A3 Reduction of gelatin cross-linking |
| 07/29/2004 | WO2003094850A3 Lipid a and other carbohydrate ligand analogs |
| 07/29/2004 | WO2003092621A3 Composition and method for dermatological treatment |
| 07/29/2004 | WO2003090640A3 Microbial cellulose wound dressing for treating chronic wounds |
| 07/29/2004 | WO2003082262A3 Compositions of venlafaxine base |
| 07/29/2004 | WO2003044076A8 Bioerodible poly(ortho esters) containing amine groups, and block copolymers containing them |
| 07/29/2004 | WO2003037295A3 Micelle compositions containing pegylated phospholipids and a photosensitizer |
| 07/29/2004 | US20040147907 Dual electrode advanced electrochemical delivery system |
| 07/29/2004 | US20040147906 Implantable interface system |
| 07/29/2004 | US20040147905 Drug delivery device |
| 07/29/2004 | US20040147904 Methods and devices for delivery of agents to breast milk ducts |
| 07/29/2004 | US20040147737 cellulose ether esters of lactic acid and of hydroxyacetic acid; slow-release pharmaceutical preparations |
| 07/29/2004 | US20040147616 Immersion foot in alcohol solution containing drug; drug penetration skin |
| 07/29/2004 | US20040147609 Liquid drug preparations |
| 07/29/2004 | US20040147607 Storage stability |
| 07/29/2004 | US20040147606 Medicinal compositions |
| 07/29/2004 | US20040147605 Mixture of antitussive agent and fudosteine |
| 07/29/2004 | US20040147578 Use of lipoaminoacids as absorption promoters in a pharmaceutical composition |
| 07/29/2004 | US20040147564 Combinations of glimepiride and the thiazolidinedione for treatment of diabetes |
| 07/29/2004 | US20040147537 Method for treating cancer with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof |
| 07/29/2004 | US20040147500 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 07/29/2004 | US20040147491 Prevent, maintenance of Dna damage; administering compound which forms nicotinamide-adenine dinucleotide |
| 07/29/2004 | US20040147488 Method of modifying the release profile of sustained release compositions |
| 07/29/2004 | US20040147486 Antitumor, anticancer agents; osteoporosis; bone disorders; Paget's disorders |
| 07/29/2004 | US20040147484 Compositions for delivering bisphosphonates |
| 07/29/2004 | US20040147472 Antisense modulation of transforming growth factor beta receptor II expression |
| 07/29/2004 | US20040147468 Immunostimulatory nucleic acid molecules |
| 07/29/2004 | US20040147462 Method for treating roundworm infestations in animals |
| 07/29/2004 | US20040147439 Pharmaceutically stable hemostatic compositions |
| 07/29/2004 | US20040147431 Erythropoietin composition |
| 07/29/2004 | US20040146925 for diagnosis and targeted drug delivery for blood cancer and monitoring protein expression or activity of white blood cells in vitro |
| 07/29/2004 | US20040146855 Preparing ferric oxide cross-linked polysaccharide/starch/chitosan matrix for the separation, isolation, identification or purification of biological materials |
| 07/29/2004 | US20040146831 Unit dose delivery system for dental sensitivity product |
| 07/29/2004 | US20040146591 Solvent extraction, mixing with aqueous solution; drying; sterilization; drugs, food; aging resistance, cognition activators , brain disorders; incontinence; Alzheimer's disease, autism, Parkinson's disease, antiarthritic agents |
| 07/29/2004 | US20040146565 Antiinflammatory agents; separated from blood; adding silica; centrifuging |
| 07/29/2004 | US20040146564 Drug delivery; heating solution to denaturate protein andding hydrophobic compound; homogenizing mixture; coagulation |
| 07/29/2004 | US20040146563 Mixture of calcium silicate and polyvinylpyrrolidone in aqueous solution; uniform agitation with plant extract drug |
| 07/29/2004 | US20040146562 Depot formulations in the form of a suspension |
| 07/29/2004 | US20040146561 Useful in the healing of refractory fracture of elderly people and diabetic or osteoporosis patients; sustained release depot preparation, which, when applied locally, can release an active ingredient gradually |
| 07/29/2004 | US20040146560 Oriented nanostructures and methods of preparing |
| 07/29/2004 | US20040146559 Modified release profile for the active material in the core |
| 07/29/2004 | US20040146558 Oral enteric-coated preparation |
| 07/29/2004 | US20040146557 Liquid polymeric compositions for controlled release of bioactive substances |
| 07/29/2004 | US20040146556 Release at least one drug contained therein at a controlled rate of release as the tablet passes from the highly acidic gastric juices into the higher pH environment of the lower gastrointestinal tract of a subject, after oral administration |
| 07/29/2004 | US20040146554 Providing an active pharmaceutical compound; providing a basic salt as one of a powder, a suspension and a solution having a pH greater than 7; combining; delivering the non-enteric coated liquid formulation |
| 07/29/2004 | US20040146553 Compositions for oral administration of active principles requiring masking of taste |
| 07/29/2004 | US20040146551 Geodate delivery vehicles |
| 07/29/2004 | US20040146550 Block copolymers based on poly(ortho esters) containing amine groups |
| 07/29/2004 | US20040146548 Enhances percutaneous absorption of anti-inflammatory agent |
| 07/29/2004 | US20040146547 Disposal system for transdermal dosage form |
| 07/29/2004 | US20040146538 Pharmaceutical composition for oral use comprising an active principle liable to undergo a large first intestinal passage effect |
| 07/29/2004 | US20040146537 Provide stability of the drugs over prolonged period of time, and uniform distribution of the active drug |
| 07/29/2004 | US20040146535 Penetration of active substances through the tissue membrane or barrier of the target organ |
| 07/29/2004 | US20040146534 Vaccine for transcutaneous immunization |
| 07/29/2004 | US20040146519 For use in vaccines, prophylaxis and therapy of cancer |
| 07/29/2004 | US20040146485 Vaccines including as an adjuvant type 1 ifn and process related thereto |
| 07/29/2004 | US20040146477 Cosmetic or pharmaceutical agent |
| 07/29/2004 | US20040146469 Dermal penetration enhancers and drug delivery systems involving same |
| 07/29/2004 | US20040146468 With excipient; suppress or reduce the gustatory function, in particular as regards a bitter and/or sweet and/or acid taste |
| 07/29/2004 | DE10301930A1 Treatment and prevention of disease by combined enteral and parenteral administration, useful specifically for protection against poisoning by cholinesterase inhibitors |
| 07/29/2004 | CA2514879A1 Two or more enteric materials to regulate drug release |
| 07/29/2004 | CA2513399A1 Treatment of cancer with 2-deoxyglucose |
| 07/29/2004 | CA2513279A1 Pharmaceutical aerosol composition |
| 07/29/2004 | CA2512801A1 Therapeutic microfoam |
| 07/29/2004 | CA2512680A1 Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants |
| 07/29/2004 | CA2512672A1 Methods of treating lung diseases |
| 07/29/2004 | CA2512320A1 Contact lens and eye drop rewetter compositions and their uses |
| 07/29/2004 | CA2512251A1 Ophthalmic compositions containing loratadine |
| 07/29/2004 | CA2512176A1 Anti-protozoal compositions comprising diclazuril |
| 07/29/2004 | CA2509251A1 Method of treating cognitive decline due to sleep deprivation and stress |
| 07/29/2004 | CA2477221A1 Simple tablet compression using gelatin |
| 07/28/2004 | EP1440962A1 Stabilized compositions of aqueous reduced coenzyme q solution |
| 07/28/2004 | EP1440686A1 Aerosol compositions |
| 07/28/2004 | EP1440114A1 Material consisting of at least a biodegradable polymer and cyclodextrins |
| 07/28/2004 | EP1439945A1 A system and method for uniaxial compression of an article, such as a three-dimensionally printed dosage form |
| 07/28/2004 | EP1439878A2 Method and apparatus for dispensing inhalator medicament |
| 07/28/2004 | EP1439876A2 A device, method and resistive element for vaporising a medicament |
| 07/28/2004 | EP1439871A1 Microneedle transport device |
| 07/28/2004 | EP1439860A1 Magnetic nanodispersion comprising cyclodextrines and method for the production thereof |